Results 1 to 10 of about 5,910,870 (299)
Clotting activity of polyphosphate-functionalized silica nanoparticles. [PDF]
AbstractWe present a silica nanoparticle (SNP) functionalized with polyphosphate (polyP) that accelerates the natural clotting process of the body. SNPs initiate the contact pathway of the blood‐clotting system; short‐chain polyP accelerates the common pathway by the rapid formation of thrombin, which enhances the overall blood‐clotting system, both by
Kudela D +12 more
europepmc +11 more sources
High Milk-Clotting Activity Expressed by the Newly Isolated Paenibacillus spp. Strain BD3526. [PDF]
Paenibacillus spp. BD3526, a bacterium exhibiting a protein hydrolysis circle surrounded with an obvious precipitation zone on skim milk agar, was isolated from raw yak (Bos grunniens) milk collected in Tibet, China.
Hang F +8 more
europepmc +4 more sources
Plant Milk-Clotting Enzymes for Cheesemaking
The reduced availability and the increasing prices of calf rennet, coupled to the growing global demand of cheese has led, worldwide, to explore alternative clotting enzymes, capable to replace traditional rennet, during the cheesemaking.
Alessandra Pino +2 more
exaly +4 more sources
Obtaining of Recombinant Camel Chymosin and Testing Its Milk-Clotting Activity on Cow's, Goat's, Ewes', Camel's and Mare's Milk. [PDF]
In the cheese-making industry, commonly chymosin is used as the main milk-clotting enzyme. Bactrian camel (Camelus bactrianus) chymosin (BacChym) has a milk-clotting activity higher than that of calf chymosin for cow’s, goat’s, ewes’, mare’s and camel’s ...
Akishev Z +8 more
europepmc +2 more sources
Trypsin is as procoagulant as factor XIIa. [PDF]
To help shed light on the roles of the contact pathway of blood clotting, we quantified the relative procoagulant activities of each of the serine proteases of the clotting cascade.
Smith SA, Morrissey JH.
europepmc +2 more sources
PROTEOLYTIC ACTIVITY OF MILK-CLOTTING ENZYMES OF DIFFERENT ORIGIN [PDF]
The ratio of the milk-clotting activity (MCA) and proteolytic activity (PA) was compared for milk-clotting enzyme preparations (MEP) based on recombinant chymosin, chymosin of animal origin and microbial origin.
D. S. Myagkonosov +3 more
doaj +2 more sources
A comprehensive multicenter study assessing the impact of abelacimab, asundexian, and milvexian on coagulation assays. [PDF]
: Phase 3 trials evaluating inhibitors of coagulation factor XI (FXI) and/or its activated form (FXIa) as novel anticoagulant drugs are ongoing. These agents include parenteral monoclonal antibody (abelacimab) and oral small molecules (milvexian ...
Goubeau L +27 more
europepmc +2 more sources
<i>In vitro</i> comparison of the effects of abelacimab, dalteparin, and apixaban on catheter-induced clotting and thrombin generation. [PDF]
Background: Abelacimab is a fully human monoclonal antibody that binds factor XI, blocking its activation and activity. It is being compared with apixaban and dalteparin in patients with cancer-associated venous thromboembolism.
Yin R, Guo X, Fredenburgh JC, Weitz JI.
europepmc +2 more sources
Research background. A few studies have investigated Cynara scolymus enzymes as a substitute for calf rennet in cheese making. They used aqueous extracts prepared by maceration of plant material and stored by freezing.
Valentina Crosetti +3 more
doaj +1 more source
A comprehensive method was applied to evaluate the anticoagulant activity of a novel anticoagulant peptide (NAESLRK) derived from oyster (Crassostrea gigas).
Shuzhen Cheng +5 more
doaj +1 more source

